Search

Your search keyword '"Mahdi-Rogers, M"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Mahdi-Rogers, M" Remove constraint Author: "Mahdi-Rogers, M"
32 results on '"Mahdi-Rogers, M"'

Search Results

2. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

3. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

4. Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy

5. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab:subgroup analysis of REGAIN and its extension study

8. Eculizumab Improves Fatigue in Refractory Generalized Myasthenia Gravis

9. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

12. Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)

13. Publisher Correction: Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data

14. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

15. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

16. Pilot Randomised Controlled Trial of Methotrexate for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (rmc Trial): Motor Nerve Conduction Studies

19. A pilot randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial: rationale and protocol)

22. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

24. Investigating genotype-phenotype relationship of extreme neuropathic pain disorders in a UK national cohort.

25. Sensory neuronopathies: A case series and literature review.

26. Catatonia with GABA A receptor antibodies.

27. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

28. Deterioration of tremor after treatment with rituximab in anti-MAG neuropathy.

29. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

30. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

31. Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins.

32. Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy.

Catalog

Books, media, physical & digital resources